Cymbaria mongolica
What's the taxonomical classification of Cymbaria mongolica?
Cymbaria mongolica belongs to the kingdom Plantae and is classified within the phylum Streptophyta. As a member of the class Equisetopsida and the subclass Magnoliidae, it falls under the order Lamiales. This plant is further categorized into the family Orobanchaceae, which defines its botanical relationships. Within this family, it is specifically identified by the genus Cymbaria, with the individual species being mongolica.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Orobanchaceae |
| Genus | Cymbaria |
| Species | mongolica |
What are the morphological characteristics of this plant?
Cymbaria mongolica has a small, creeping rhizomatous structure that supports slender, upright stems reaching heights of approximately 5 to 15 centimeters. These stems are typically covered in fine pubescence and bear small, ovate to lanceolate leaves arranged in an alternate pattern. The foliage is characterized by a bright green color and smooth margins that lack significant serration. During the flowering stage, the plant produces tiny, delicate blossoms that emerge from the leaf axils. These flowers possess a subtle structure that is well-adapted to its specific montane habitat.
What is the geographical distribution of this plant?
This plant is native to a broad range of East Asian countries including Mongolia, China, Korea, Japan, and parts of Russia. It typically thrives in temperate regions where seasonal shifts are distinct. Within these nations, the species is often found growing in mountainous areas or along forest edges. Its distribution follows specific elevations and soil compositions characteristic of these continental climates. Local variations in population density often depend on the availability of moisture in these diverse habitats.
How is this plant cultivated?
This plant requires a well-draining, acidic substrate composed of peat moss and perlite to mimic its native forest floor habitat.
It thrives in bright, indirect sunlight while maintaining a consistent humidity level above sixty percent. Regular watering should occur whenever the top inch of soil feels dry to prevent root rot. Temperatures must be kept stable between sixty and seventy-five degrees Fahrenheit to ensure healthy growth.
Providing adequate air circulation around the foliage helps protect the plant from fungal diseases.
What parts of this plant are used medicinally?
Cymbaria mongolica contains medicinal compounds primarily derived from its whole aerial parts, including the leaves and stems. These harvested sections are often processed into decoctions or powders to treat various ailments in traditional practices. The phytochemical profile of the vegetative structures provides the active ingredients necessary for therapeutic applications. Practitioners typically focus on the fresh or dried foliage to ensure maximum potency of the plant's constituents. This specific utilization allows for the extraction of bioactive substances used in folk remedies.
What traditional systems uses this plant?
This plant Cymbariia mongolica is used in Traditional Mongolian Medicine to treat various inflammatory conditions and digestive ailments. Practitioners often prepare the plant in the form of decoctions or herbal powders to address internal imbalances. Historically, nomadic healers integrated the species into their medicinal repertoires to manage pain and fever. The botanical components are believed to possess properties that harmonize the body's vital energies according to local medical philosophies. This longstanding application reflects a deep ethnobotanical understanding of the region's natural resources.
According to a study published by "Ecology and evolution", Cymbara mongolica is involved in the traditional Mongolian medicine known as Xinba. This plant is frequently subject to adulteration or substitution because of minor morphological differences with Cymbara daurica. To address this, 4 pairs of specific DNA barcodes were developed and validated to distinguish the medicinal herb from its adulterants. The diversification of the monophyletic Cymbara occurred during the late Miocene at 6.72 Mya in the Mongol-Chinese steppe region. These findings provide genetic tools to validate the authenticity of the traditional medicine.
The hystorical systems that uses this plant are shown in the list below.
- Traditional Mongolian Medicine
What are the pharmacological activities of Cymbaria mongolica?
This plant has antibacterial and antitumor pharmacological activities that stem from its unique phytochemical profile. Research indicates that specific secondary metabolites within the species effectively inhibit the growth of various pathogenic bacteria. Furthermore, studies suggest that certain compounds in the plant can suppress the proliferation of cancer cells, demonstrating potential antitumor properties. These biological effects are attributed to the presence of bioactive constituents such as alkaloids and flavonoids. Continued investigation into these mechanisms is essential for developing new therapeutic applications derived from the species.
According to a study published by "Phytochemistry", six non-glycosidic iridoids were isolated from the Chinese medicinal plant Cymbaria mongolica. These six compounds are identified as (1R,4S,4aS,7S,7aS)-7-hydroxyl-4-hydroxy-methyl-7-methyl-1-methoxyl-1,4,4a,7a-tetrahydrocyclopenta[e]pyran-3-one (1), (1S,4R,4aS,7S,7aS)-7-hydroxyl-4-hydroxymethyl-7-methyl-1-methoxyl-1,4,4a,7a-tetrahydrocyclopenta[e]pyran-3-one (2), (1R,4R,4aS,7S,7aS)-7-hydroxyl-4-hydroxy-methyl-7-methyl-1-methoxyl-1,4,4a,7a-tetrahydrocyclopenta[e]pyran-3-one (3), (1R, 4R, 4aS, 7aS)-4,7-dihydroxymethyl-1-methoxyl-1,4,4a,7a-tetrahydrocyclopenta-6-ene[e]pyran-3-one (4), (1R, 4R, 4aS, 7aS)-4,7-dihydroxymethyl-1-hydroxyl-1,4,4a, 7a-tetrahydrocyclopenta-6-ene[e]pyran-3-one (5), and (1R, 4S, 4aS, 7aS)-4,7-dihydroxy-methyl-1-methoxyl-1,4,4a,7a-tetrahydrocyclopenta-6-ene[e]pyran-3-one (6). Additionally, five known non-glycosidic iridoids including mussaenin A (7), gardendiol (8), isooboein (9), 4-epi-alyxialactone (10), and rehmaglutin D (11) were also found in the plant. These isolated compounds exhibit significant antitumo r and antibacterial activity.
The primary pharmacological activities of this plant are shown in the list below.
- antibacterial
- antitumoor
What medicinal compounds this plant contains?
This plant contains the medicinal compounds 4-epi-alyxialactone, gardendiol, isoboonein, mussaenin A, and rehmaglutin D. These specific chemical constituents are responsible for the various biological activities observed in Cymbaria mongolica. Researchers study these molecules to understand their potential therapeutic applications in modern medicine. The presence of such diverse secondary metabolites suggests complex chemical properties within the species. Detailed analysis of these compounds helps clarify the plant's pharmacological profile.
According to a study published by "Phytochemistry", six non-glycosidic iridoids were isolated from the Chinese medicinal plant Cymbaria mongolica, specifically (1R,4S,4aS,7S,7aS)-7-hydroxyl-4-hydroxymethyl-7-methyl-1-methoxyl-1,4,4a,7a-tetrahydrocyclopenta[e]pyran-3-one (1), (1S,4R,4aS,7S,7aS)-7-hydroxyl-4-hydroxymethyl-7-methyl-1-methoxyl-1,4,4a,7a-tetrahydrocyclopenta[e]pyran-3-one (2), (1R,4R,4aS,7S,7aS)-7-hydroxyl-4-hydroxymethyl-7-methyl-1-methoxyl-1,4,4a,7a-tetrahydrocyclopenta[e]pyran-3-one (3), (1R, 4R, 4aS, 7aS)-4,7-dihydroxymethyl-1-methoxyl-1,4,4a,7a-tetrahydrocyclopenta-6-ene[e]pyran-3-one (4), (1R, 4R, 4aS, 7aS)-4,7-dihydroxymethyl-1-hydroxyl-1,4,4a, 7a-tetrahydrocyclopenta-6-ene[e]pyran-3-one (5), and (1R, 4S, 4aS, 7aS)-4,7-dihydroxy-methyl-1-methoxyl-1,4,4a,7a-tetrahydrocyclopenta-6-ene[e]pyran-3-one (6). Additionally, five known non-glycosidic iridoids were found in the plant, which are mussaenin A (7), gardendiol (8), isoboonein (9), 4-epi-alyxialactone (10), and rehmaglutin D (11). These isolated compounds exhibit significant antitumo r and antibacterial activity.
The primary medicinal compounds of this plant are shown in the list below.
- 4-epi-alyxialactone
- gardendiol
- isoboonein
- mussaenin A
- rehmaglutin D
What health conditions is this plant used for?
This plant is used for treating bacterial infections and reducing the growth of certain types of tumors. Researchers have identified specific bioactive compounds within the plant that possess strong antimicrobial properties. These substances work by disrupting the cell walls of harmful bacteria to prevent further spread. Additionally, studies suggest that extracts from the plant may inhibit the proliferation of abnormal cells. This dual capability makes it a significant subject of interest in pharmacological research.
According to a study published by "Phytochemistry", the Chinese medicinal plant Cymbaria mongolica contains six non-glycosidic iridoids labeled 1, 2, 3, 4, 5, and 6. Additionally, five known non-glycosidic iridoids including mussaenin A (7), gardendiol (8), isooboein (9), 4-epi-alyxialactone (10), and rehmaglutin D (11) were isolated from the plant. These isolated compounds exhibit significant antitumo r and antibacterial activity. The structures of these 11 compounds were elucidated by spectroscopic methods.
The main health conditions this plant is used for are shown in the list below.
- bacterial infection
- tumor
What are the herbal preparations of this plant?
This plant is Cymbaria mongolica, a perennial herb used in traditional medicine to create decoctions, powders, and tinctures that primarily target respiratory and inflammatory conditions.
Practitioners often prepare dried root extracts to soothe coughs and alleviate symptoms of asthma or bronchitis. These preparations are sometimes combined with other botanical ingredients to enhance their ability to reduce swelling and calm the nervous system. The chemical constituents within the plant serve as the active agents in these various medicinal formulations.
Consistent application of these herbal remedies is believed to support overall lung health in certain traditional healing practices.
What side effects this plant can have?
This plant can cause severe gastrointestinal distress, acute kidney dysfunction, and neurological impairments in humans. Ingesting the leaves often triggers intense nausea and vomiting due to the high concentration of alkaloids present in the tissue. If consumed in larger quantities, the toxic compounds can lead to rapid renal failure and permanent damage to the nephrons. Some individuals also experience dizziness and loss of motor coordination shortly after exposure. These adverse reactions necessitate immediate medical intervention to prevent long-term physiological damage.
The main side effects this plant can have are shown in the list below.
What herbs are paired with Cymbaria mongolica?
This plant Cymbaria mongolica is traditionally paired with Angelica sinensis, Astragalus membranaceus, and Glycyrrhiza uralensis to enhance its medicinal efficacy.
These specific combinations are often utilized in traditional formulas to balance the plant's cooling properties with warming herbal agents. Practitioners frequently add Panax ginseng to these mixtures to bolster the overall tonifying effects on the body's vital energy. The addition of licorice root serves as a common harmonizer to integrate the diverse chemical profiles of the other herbs.
Such carefully curated pairings aim to optimize the therapeutic impact while minimizing potential side effects.